...
首页> 外文期刊>HIV medicine >Predictive factors for immunological and virological endpoints in Thai patients receiving combination antiretroviral treatment.
【24h】

Predictive factors for immunological and virological endpoints in Thai patients receiving combination antiretroviral treatment.

机译:泰国患者接受联合抗逆转录病毒治疗的免疫学和病毒学终点指标的预测因素。

获取原文
获取原文并翻译 | 示例

摘要

BACKGROUND: Routine CD4 count and HIV viral load monitoring is a financial barrier in developing countries. METHODS: We assessed factors associated with CD4 counts < or =200 cells/microL and detectable viral load in Thai HIV-infected patients receiving antiretroviral therapy (ART) at the HIV Netherlands Australia Thailand Research Collaboration and the Thai Red Cross AIDS Research Centre (HIV-NAT). Univariate and multivariate Cox proportional hazards models for multiple treatment failures were used to determine factors related to CD4 counts < or =200 cells/microL and detectable viral load. Multivariate Cox proportional hazards models for CD4 counts < or =200 cells/microL were developed with and without viral load in order to build models applicable to contexts in which viral load is not available. RESULTS: Four hundred and seventeen patients were included in the study. Fifty-four per cent were male, and the median CD4 count and log(10) viral load at baseline were 283 cells/microL and 4.3 log(10) HIV-1 RNA copies/mL, respectively. Independent factors related to CD4 count < or =200 cells/microL were CD4 count at baseline [hazards ratio (HR) 0.20/100 cells/microL; 95% confidence interval (CI) 0.17-0.23] and changes in CD4 count (HR 0.22/100 cells/microL; 95% CI 0.17-0.28). Factors in multivariate models (in which viral load was considered for inclusion) were CD4 count at baseline (HR 0.21/100 cells/microL; 95% CI 0.18-0.24), changes in CD4 count (HR 0.25/100 cells/microL; 95% CI 0.19-0.32) and detectable viral load (HR 1.94; 95% CI 1.20-3.13). Predictive factors (independent of viral load) were triple ART or highly active antiretroviral therapy (HAART) (HR 0.28; 95% CI 0.22-0.36) and detectable viral load at baseline (HR 2.96; 95% CI 2.24-3.91). Conclusions CD4 count at baseline and changes in CD4 count were important in predicting CD4 counts < or =200 cells/microL. Triple ART and detectable viral load at baseline were important in predicting detectable viral load.
机译:背景:常规CD4计数和HIV病毒载量监测是发展中国家的财务障碍。方法:我们在荷兰荷兰荷兰泰国研究合作组织和泰国红十字会艾滋病研究中心(HIV)评估了接受抗逆转录病毒疗法(ART)的泰国HIV感染患者中CD4计数≤200细胞/微升和可检测病毒载量的相关因素-NAT)。用于多种治疗失败的单因素和多因素Cox比例风险模型用于确定与CD4计数≤200细胞/微升和可检测的病毒载量相关的因素。针对有或没有病毒载量的CD4计数<或= 200细胞/微升的多变量Cox比例风险模型,以建立适用于没有病毒载量的情况的模型。结果:417例患者被纳入研究。 54%为男性,基线时的CD4计数中位数和log(10)病毒载量分别为283细胞/微升和4.3 log(10)HIV-1 RNA拷贝/毫升。与CD4计数≤200细胞/微升相关的独立因素是基线时的CD4计数[危险比(HR)0.20 / 100细胞/微升; 95%置信区间(CI)0.17-0.23]和CD4计数的变化(HR 0.22 / 100细胞/ microL; 95%CI 0.17-0.28)。多元模型(考虑包括病毒载量)的因素包括基线时的CD4计数(HR 0.21 / 100细胞/微升; 95%CI 0.18-0.24),CD4计数的变化(HR 0.25 / 100细胞/微升; 95 %CI 0.19-0.32)和可检测的病毒载量(HR 1.94; 95%CI 1.20-3.13)。预测因素(与病毒载量无关)是三联抗逆转录病毒疗法或高活性抗逆转录病毒疗法(HAART)(HR 0.28; 95%CI 0.22-0.36)和基线时可检测到的病毒载量(HR 2.96; 95%CI 2.24-3.91)。结论基线时的CD4计数和CD4计数的变化对于预测CD4计数≤200细胞/微升很重要。在预测基线可检测的病毒载量时,三重抗病毒治疗和基线可检测的病毒载量很重要。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号